Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
24.80
-0.20 (-0.80%)
Mar 28, 2025, 3:04 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 4.53B CNY in the quarter ending September 30, 2024, a decrease of -69.46%. This brings the company's revenue in the last twelve months to 36.43B, down -26.71% year-over-year. In the year 2023, Chongqing Zhifei Biological Products had annual revenue of 52.92B with 38.30% growth.
Revenue (ttm)
36.43B
Revenue Growth
-26.71%
P/S Ratio
1.63
Revenue / Employee
5.57M
Employees
6,545
Market Cap
59.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
Dec 31, 2020 | 15.19B | 4.60B | 43.48% |
Dec 31, 2019 | 10.59B | 5.36B | 102.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |